A randomized controlled single-blind trial was conducted in 70 secondary care centers across Germany comparing 12 weeks of CBT with sertraline in 251 patients with type 1 or 2 diabetes ( mean HbA1c 9.3 % , 78 mmol/mol ) and major depression ( Structured Clinical Interview for DSM-IV [ SCID ] ) .